Literature DB >> 33479653

Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors.

M I Osella1, M O Salazar1, M D Gamarra2, D M Moreno3, F Lambertucci4, D E Frances4, R L E Furlan1.   

Abstract

A series of simple N-arylbenzenesulfonyl histamine derivatives were prepared and screened against α-glucosidase. Inhibition was in the micromolar range for several N α,N τ-di-arylsulfonyl compounds, with N α,N τ-di-4-trifluorobenzenesulfonyl histamine (IId) being the best inhibitor. Compound IId is a reversible and competitive α-glucosidase inhibitor, and presented good selectivity with respect to other target enzymes, including β-glucosidase and α-amylase, and interesting predicted physicochemical properties. Docking studies have been run to postulate ligand-enzyme interactions to account for the experimental results. In vivo, compound IId produced a similar hypoglycemic effect to acarbose with half of its dose. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479653      PMCID: PMC7489258          DOI: 10.1039/c9md00559e

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  51 in total

1.  Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.

Authors:  Nik Khairunissa Nik Abdullah Zawawi; Muhammad Taha; Norizan Ahmat; Nor Hadiani Ismail; Abdul Wadood; Fazal Rahim
Journal:  Bioorg Chem       Date:  2016-12-26       Impact factor: 5.275

2.  Using crystallographic water properties for the analysis and prediction of lectin-carbohydrate complex structures.

Authors:  C Modenutti; D Gauto; L Radusky; J Blanco; A Turjanski; S Hajos; Ma Marti
Journal:  Glycobiology       Date:  2014-09-28       Impact factor: 4.313

3.  α-1-C-butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia.

Authors:  Atsushi Kato; Erina Hayashi; Saori Miyauchi; Isao Adachi; Tatsushi Imahori; Yoshihiro Natori; Yuichi Yoshimura; Robert J Nash; Hideyuki Shimaoka; Izumi Nakagome; Jun Koseki; Shuichi Hirono; Hiroki Takahata
Journal:  J Med Chem       Date:  2012-11-19       Impact factor: 7.446

4.  The global implications of diabetes and cancer.

Authors:  Yuankai Shi; Frank B Hu
Journal:  Lancet       Date:  2014-06-07       Impact factor: 79.321

Review 5.  Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.

Authors:  Manoj Dhameja; Preeti Gupta
Journal:  Eur J Med Chem       Date:  2019-04-30       Impact factor: 6.514

6.  Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.

Authors:  Musa Özil; Mustafa Emirik; Ali Beldüz; Serdar Ülker
Journal:  Bioorg Med Chem       Date:  2016-08-20       Impact factor: 3.641

7.  Antioxidant rich grape pomace extract suppresses postprandial hyperglycemia in diabetic mice by specifically inhibiting alpha-glucosidase.

Authors:  Shelly Hogan; Lei Zhang; Jianrong Li; Shi Sun; Corene Canning; Kequan Zhou
Journal:  Nutr Metab (Lond)       Date:  2010-08-27       Impact factor: 4.169

8.  C-branched iminosugars: α-glucosidase inhibition by enantiomers of isoDMDP, isoDGDP, and isoDAB-L-isoDMDP compared to miglitol and miglustat.

Authors:  Sarah F Jenkinson; Daniel Best; A Waldo Saville; James Mui; R Fernando Martínez; Shinpei Nakagawa; Takahito Kunimatsu; Dominic S Alonzi; Terry D Butters; Caroline Norez; Frederic Becq; Yves Blériot; Francis X Wilson; Alexander C Weymouth-Wilson; Atsushi Kato; George W J Fleet
Journal:  J Org Chem       Date:  2013-06-05       Impact factor: 4.354

9.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

Review 10.  Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry.

Authors:  Minghao Feng; Bingqing Tang; Steven H Liang; Xuefeng Jiang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.